Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

Today's News. Tomorrow's Perspective. Today's News. Tomorrow's Perspective.

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.

  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
  • Home
  • Breaking News
  • Business
  • Sports
  • Health
  • Politics
  • Technology & AI
  • World
Close

Search

Subscribe
Bayer agrees to pay Roundup claims in settlement that could cost billions: NPR
Breaking NewsFeatured

Bayer agrees to pay Roundup claims in settlement that could cost billions: NPR

Eleon
By Eleon
November 21, 2026 3 Min Read
Comments Off on Bayer agrees to pay Roundup claims in settlement that could cost billions: NPR

Bottles of Roundup weed killer are displayed on a shelf at a Home Depot store on June 25, 2026 in North Hollywood, California.

Bottles of Roundup weed killer are displayed on a shelf at a Home Depot store on June 25, 2026 in North Hollywood, California.

Justin Sullivan/Getty Images North America


hide caption

Justin Sullivan/Getty Images North America

Agrochemical and biotechnology giant Bayer has agreed to pay billions of dollars to people who sued the company, alleging that the weedkiller Roundup caused their cancer.

A Missouri judge gave final approval to the nationwide app on Friday regulation it could cost the company as much as $7.25 billion in the coming years.

The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma – a blood cancer they say is linked to glyphosate, which is the main ingredient in Roundup.

According to the circuit court settlement, those affected could receive between $10,000 and $165,000 in compensation, depending on whether their work in agriculture or other occupations exposed them to higher levels of glyphosate, the age at which they were diagnosed with non-Hodgkin’s lymphoma and other factors.

In a statementBayer CEO Bill Anderson called the settlement a “decisive milestone” that will “mitigate the risks” of ongoing and future litigation.

Presiding Judge Timothy Boyer said it was “one of the largest tort and personal injury class action settlements in history.”

A French farmer sprays the glyphosate herbicide Roundup 720 produced by US agrochemical giant Monsanto in 2018 on a no-till corn field in northwest France. The U.S. Supreme Court on Monday heard a dispute over the labels of the popular pesticide Roundup, which thousands of plaintiffs accuse of causing their cancers.

Earlier this year, the U.S. Supreme Court ruled in favor of Bayer, the German company that now owns Monsanto, finding that it could be shielded from lawsuits in state courts over allegations that it failed to warn consumers about the carcinogenic effects of glyphosate.

Roundup is the most widely used weedkiller in the world.

The attorney representing the plaintiffs, Christopher Seeger, said in a statement that “today’s final approval order ensures compensation for Roundup cancer victims who have waited more than a decade for justice.”

Bayer to pay more than $10 billion to resolve cancer lawsuit over weedkiller raid

The latest settlement adds to a precedent in which Bayer agreed to pay between $10 billion and $11 billion to settle more than 100,000 Roundup claims.

More than a decade ago, the World Health Organization’s cancer agency concluded that glyphosate was likely carcinogenic to humans. Leading scientists in the field of environmental health have echoes these concerns just this year.

But Bayer has strongly denied that its product causes cancer.

The Environmental Protection Agency also concluded that it “has not identified any risks of concern from the use of glyphosate, including for cancer,” although the agency is currently conducting a review of evidence related to human health after facing intense pressure from advocates and some scientists.

Concerns about the safety of glyphosate have been a concern for supporters of Health Secretary Robert F. Kennedy Jr. and his Make America Healthy Again agenda.

However, the Trump administration has taken steps to support the herbicide maker, siding with Bayer in the Supreme Court case and issuing an executive order to promote domestic production of glyphosate.

Several years ago, the company removed glyphosate from its U.S. residential products, although it is still used in the agricultural industry.

Gn headline

Views: 5
Eleon
Author

Eleon

With a passion for accurate reporting and in-depth research, Eleon covers breaking news, industry developments, and emerging trends that matter to readers worldwide. Their work focuses on delivering factual, balanced, and easy-to-understand journalism backed by reliable sources.At DailyVoxa, every article is produced in accordance with our Editorial Policy, Fact-Checking Policy, and Ethics Policy to ensure accuracy, transparency, and editorial independence.

Follow Me
Other Articles
Sources: Giants open to trade offers for star pitcher Logan Webb
Previous

Sources: Giants open to trade offers for star pitcher Logan Webb

Another earthquake rocks Southern California, this time off the coast of San Pedro
Next

Another earthquake rocks Southern California, this time off the coast of San Pedro

Deliver fast, factual, and easy-to-understand news covering global events, technology, business, science, AI, health, entertainment, and lifestyle.
  • About Us
  • Accessibility Statement
  • Advertise With Us
  • AI Usage & Transparency Policy
  • Contact us
  • Cookie Policy
  • Corrections Policy
  • Meet Our Team
  • Privacy Policy
    • Disclaimer
    • DMCA & Copyright Policy
    • Editorial Policy
    • Ethics Policy
    • Fact-Checking Policy
  • Terms and Conditions
Copyright 2026 — Today's News. Tomorrow's Perspective.. All rights reserved.